Orphazyme
IPOPublic · Copenhagen, Denmark · Founded 2009 · $34.0M raised
- Headquarters
- Copenhagen
- Employees
- 51–200
- Founded
- 2009
- Business Model
- B2B
- Website
- orphazyme.com
- Total Funding
- $34.0M
- Last Round
- $20.0M Series BMar 2017
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.
About
Biopharmaceutical company developing novel therapeutics for rare diseases using heat-shock protein expertise.
Summary
Orphazyme is a Biotech company based in Copenhagen, Denmark, founded in 2009. It has raised $34.0M in total across 2 rounds, most recently a $20.0M Series B round in Mar 2017. Investors include Heartcore, Eurazeo and Kurma Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2022
Sign up to see all 4 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/orphazyme"><img src="https://indexed.vc/api/badge/company/orphazyme" alt="Orphazyme on Indexed.vc" width="260" height="76" /></a>